Valo Health is a technology company dedicated to transforming the drug discovery and development process through the integration of human-centric data and AI-powered technology. Founded by Flagship Pioneering and headquartered in Lexington, MA, with additional offices in New York, NY, Valo aims to accelerate the creation of life-changing drugs while reducing costs, time, and failure rates. The company’s Opal Computational Platform™ serves as a unified architecture that harnesses high-quality biological data to generate valuable insights, supporting a robust pipeline of programs across various disease areas, including cardiovascular, metabolic, renal, oncology, and neurodegenerative diseases. Valo is committed to fostering a diverse and inclusive environment, leveraging a multi-disciplinary team of experts to achieve better outcomes for patients faster.